LR769 in Congenital Hemophilia Patients With Inhibitors Undergoing Elective Surgery or Invasive Procedures

NCT02548143 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia

Interventions

BIOLOGICAL: Coagulation Factor VIIa (Recombinant)

Sponsor

Laboratoire français de Fractionnement et de Biotechnologies

Collaborators

[object Object]